Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

about

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

Item

http://www.wikidata.org/entity/Q36016022

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@ast

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@en

type

Item

label

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@ast

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@en

prefLabel

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@ast

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@en

P1476

Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.

@en

P2093

Antoni Torres

http://www.w3.org/2001/XMLSchema#string

Paolo Durando

http://www.w3.org/2001/XMLSchema#string

Saul N Faust

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000.

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review

Meningococcal polysaccharide-protein conjugate vaccines.

P304

934504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1155/2015/934504

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281683072

http://www.w3.org/2001/XMLSchema#string

P698

26355657

http://www.w3.org/2001/XMLSchema#string

P932

4556328

http://www.w3.org/2001/XMLSchema#string